Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q1 2014 · 10-Q
Revenue$4.76B$4.76B−1.9% vs Q1 2013 Net Income$375.00M$375.00M−31.2% vs Q1 2013 EPS Diluted$0.24$0.24−29.4% vs Q1 2013 Gross Profit$2,354,000,000−5.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flow$336,000,000−27.0% Free Cash Flowderived$81,000,000−56.5% Margins · derivedGross margin49.5%−1.6 pt vs Q1 2013
Operating margin7.7%−5.0 pt vs Q1 2013
Net margin7.9%−3.4 pt vs Q1 2013
ended Mar 31, 2014 · filed May 7, 2014 · 37 d after period end